Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM)

NCT06858111 is registered in ClinicalTrials.gov with Gameto, Inc. as lead sponsor.

NCT NCT06858111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06858111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM)
Lead sponsor
Gameto, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
April 17, 2025
Completion date
January 31, 2028
Enrollment
500 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

in vitro maturation of oocytes